×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
VYNE – vyne therapeutics inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
VYNE
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/18
08:07 am
vyne
VYNE Therapeutics Inc. (NASDAQ: VYNE) is now covered by analysts at BTIG Research. They set a "buy" rating and a $8.00 price target on the stock.
Low
Report
VYNE Therapeutics Inc. (NASDAQ: VYNE) is now covered by analysts at BTIG Research. They set a "buy" rating and a $8.00 price target on the stock.
11/9
08:42 am
vyne
VYNE Therapeutics Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags [Yahoo! Finance]
Low
Report
VYNE Therapeutics Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags [Yahoo! Finance]
11/8
08:46 am
vyne
VYNE Therapeutics Inc. (NASDAQ: VYNE) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $5.75 price target on the stock.
Low
Report
VYNE Therapeutics Inc. (NASDAQ: VYNE) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $5.75 price target on the stock.
11/7
08:00 am
vyne
VYNE Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update
Medium
Report
VYNE Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update
9/26
07:08 am
vyne
We Think VYNE Therapeutics (NASDAQ:VYNE) Needs To Drive Business Growth Carefully [Yahoo! Finance]
Low
Report
We Think VYNE Therapeutics (NASDAQ:VYNE) Needs To Drive Business Growth Carefully [Yahoo! Finance]
9/12
12:14 pm
vyne
VYNE Therapeutics Inc. (NASDAQ: VYNE) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $5.75 price target on the stock.
Medium
Report
VYNE Therapeutics Inc. (NASDAQ: VYNE) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $5.75 price target on the stock.
9/12
08:00 am
vyne
VYNE Therapeutics Announces Positive Phase 1a SAD Data for VYN202, a Novel BD2-Selective BET Inhibitor
Medium
Report
VYNE Therapeutics Announces Positive Phase 1a SAD Data for VYN202, a Novel BD2-Selective BET Inhibitor
9/3
08:00 am
vyne
VYNE Therapeutics to Participate in September Investor Conferences
Medium
Report
VYNE Therapeutics to Participate in September Investor Conferences
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/14
03:35 pm
vyne
Form SC 13G/A VYNE Therapeutics Inc. Filed by: Soleus Capital Master Fund, L.P.
Low
Report
Form SC 13G/A VYNE Therapeutics Inc. Filed by: Soleus Capital Master Fund, L.P.
11/12
04:07 pm
vyne
Form ARS VYNE Therapeutics Inc. For: Dec 31
Medium
Report
Form ARS VYNE Therapeutics Inc. For: Dec 31
11/12
04:02 pm
vyne
Form DEF 14A VYNE Therapeutics Inc. For: Dec 12
Medium
Report
Form DEF 14A VYNE Therapeutics Inc. For: Dec 12
11/7
04:09 pm
vyne
Form 10-Q VYNE Therapeutics Inc. For: Sep 30
Low
Report
Form 10-Q VYNE Therapeutics Inc. For: Sep 30
11/7
08:03 am
vyne
Form 8-K VYNE Therapeutics Inc. For: Nov 07
Medium
Report
Form 8-K VYNE Therapeutics Inc. For: Nov 07
10/2
04:15 pm
vyne
Form 4 VYNE Therapeutics Inc. For: Sep 30 Filed by: Harsch Mutya
Medium
Report
Form 4 VYNE Therapeutics Inc. For: Sep 30 Filed by: Harsch Mutya
10/2
04:15 pm
vyne
Form 4 VYNE Therapeutics Inc. For: Sep 30 Filed by: Stuart Iain
Medium
Report
Form 4 VYNE Therapeutics Inc. For: Sep 30 Filed by: Stuart Iain
10/2
04:15 pm
vyne
Form 4 VYNE Therapeutics Inc. For: Sep 30 Filed by: Domzalski David
Medium
Report
Form 4 VYNE Therapeutics Inc. For: Sep 30 Filed by: Domzalski David
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: